Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Inflammatory monocytes hinder antiviral B cell responses.

Sammicheli S, Kuka M, Di Lucia P, de Oya NJ, De Giovanni M, Fioravanti J, Cristofani C, Maganuco CG, Fallet B, Ganzer L, Sironi L, Mainetti M, Ostuni R, Larimore K, Greenberg PD, de la Torre JC, Guidotti LG, Iannacone M.

Sci Immunol. 2016 Oct 21;1(4). pii: eaah6789.

2.

Response: Commentary: Zika Virus: the Latest Newcomer.

Saiz JC, Blázquez AB, De Oya NJ, Merino-Ramos T, Martín-Acebes MA, Escribano-Romero E, Vázquez-Calvo Á.

Front Microbiol. 2016 Sep 7;7:1398. doi: 10.3389/fmicb.2016.01398. eCollection 2016. No abstract available.

3.

Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).

Escribano-Romero E, Gamino V, Merino-Ramos T, Blázquez AB, Martín-Acebes MA, de Oya NJ, Gutiérrez-Guzmán AV, Escribano JM, Höfle U, Saiz JC.

Vaccine. 2013 Sep 23;31(41):4523-7. doi: 10.1016/j.vaccine.2013.07.071. Epub 2013 Aug 6.

PMID:
23933372
4.

A single amino acid substitution in the core protein of West Nile virus increases resistance to acidotropic compounds.

Martín-Acebes MA, Blázquez AB, de Oya NJ, Escribano-Romero E, Shi PY, Saiz JC.

PLoS One. 2013 Jul 18;8(7):e69479. doi: 10.1371/journal.pone.0069479. Print 2013.

5.

Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.

Alonso-Padilla J, de Oya NJ, Blázquez AB, Escribano-Romero E, Escribano JM, Saiz JC.

Vaccine. 2011 Feb 17;29(9):1830-5. doi: 10.1016/j.vaccine.2010.12.081. Epub 2011 Jan 4.

PMID:
21211580

Supplemental Content

Loading ...
Support Center